This image is not available for purchase in your country.

Tivozanib kidney cancer drug

Tivozanib kidney cancer drug

C042/6357

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR P. MARAZZI / SCIENCE PHOTO LIBRARY DR P. MARAZZI / SCIENCE PHOTO LIBRARY

Restrictions:

Editorial use only.

Caption

Tivozanib kidney cancer drug. Close-up of a tub containing capsules of the kidney cancer drug tivozanib, marketed under the name Fotivda. Tivozanib is an oral VEGF receptor tyrosine kinase inhibitor used for the treatment of first line (treatment naive) patients with renal cell carcinoma.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}